By Editor

I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…

Search Stock Profiles

Latest News

AAPL: Apple Stock – Buy or Sell This Tech Icon?

Apple (AAPL) is the glossy tech heartthrob strutting its stuff at $223.26 (StockAnalysis.com) as of March…

By Editor

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From It

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From ItPalantir (PLTR)’s earnings…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

BNTX: BioNTech – Buy or Sell This Biotech Trailblazer?

BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…

By Editor
2 Min Read

AMGN: Amgen – Buy or Sell This Biotech Bruiser?

Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+ market cap as of…

By Editor
2 Min Read

REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?

Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…

By Editor
2 Min Read